Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ChemoMetec A/S Maintains FY 2013/2014 Financial Guidance


Friday, 15 Nov 2013 02:04am EST 

ChemoMetec A/S announced that the Company maintains its fiscal year 2013/2014 financial guidance. The Company still expects its revenue to be in the DKK 43-45 million range and EBITDA to be in a level of DKK 6-8 million in the fiscal year 2013/2014. 

Company Quote

16.5
-0.9 -5.17%
5:04am EDT